» Articles » PMID: 36172688

Factors Associated with Dysplastic Changes in Sinonasal Inverted Papilloma: Study of Tumor Infiltrating Lymphocytes (TILs) FOXP3, CD4, CD8, and Expression of P53

Overview
Specialty Oncology
Date 2022 Sep 29
PMID 36172688
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study examine FOXP3, CD4, CD8 and p53 expression in the transformation of the Sinonasal Inverted Papilloma (SIP) malignancy into sinonasal carcinoma.

Materials And Methods: This study used a cross-sectional approach. The research sample from thirty-six paraffin block preparations with the diagnosis of SIP. Then, immunohistochemical staining was performed using FOXP3 mouse monoclonal antibody (236A/E7), CD8 rabbit monoclonal antibody (CD8/1179R), CD4 mouse monoclonal antibody (4B12) and p53 rabbit monoclonal antibody.  Results: There was a significant difference between Foxp3 expression in SIP without dysplasia and SIP with dysplasia (p= 0.013). There was no significant difference between the expression of CD4 and CD8 in the two groups with p-values 0.1 and 0.062, respectively. The mean percentage of positive p53 expression in SIP without dysplasia was 0.45+0.63 and in the SIP with dysplasia 29.31+38.96. There was a significant difference between the two groups (p<0.001).

Conclusion: FOXP3 and p53 were overexpressed in SIP with malignant transformation. FOXP3 together with p53 status is associated with dysplastic changed in the SIP. FOXP3 and p53 status could be potential biomarker of malignant transformation in sinonasal inverted papilloma.

Citing Articles

Atypical Sinonasal Inverted Papilloma - A Case Report.

Kumar R, Varsha S, Kumar K, Kumar B, Pal S Ann Maxillofac Surg. 2025; 14(2):236-239.

PMID: 39957878 PMC: 11828048. DOI: 10.4103/ams.ams_64_24.


Evaluating CD4 and Foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and Colorectal Cancer Patients.

Asri N, Nazemalhosseini Mojarad E, Taleghani M, Houri H, Saeedi Niasar M, Rezaei-Tavirani M Asian Pac J Cancer Prev. 2024; 25(2):647-652.

PMID: 38415552 PMC: 11077127. DOI: 10.31557/APJCP.2024.25.2.647.

References
1.
Wang M, Noel J . Etiology of sinonasal inverted papilloma: A narrative review. World J Otorhinolaryngol Head Neck Surg. 2017; 3(1):54-58. PMC: 5683660. DOI: 10.1016/j.wjorl.2016.11.004. View

2.
Kara I, Cagli S, Vural A, Yuce I, Gundog M, Deniz K . The effect of FoxP3 on tumour stage, treatment response, recurrence and survivalability in nasopharynx cancer patients. Clin Otolaryngol. 2019; 44(3):349-355. DOI: 10.1111/coa.13311. View

3.
Petersen R, Campa M, Sperlazza J, Conlon D, Joshi M, Harpole Jr D . Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer. 2006; 107(12):2866-72. DOI: 10.1002/cncr.22282. View

4.
Lee J, Roland L, Licata J, Orlowski H, Jiramongkolchai P, Piccirillo J . Morphologic, intraoperative, and histologic risk factors for sinonasal inverted papilloma recurrence. Laryngoscope. 2019; 130(3):590-596. PMC: 7323917. DOI: 10.1002/lary.28078. View

5.
Zhang Y, Li J, Mo H, Qiu F, Zheng L, Qian C . Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways. Mol Cancer. 2010; 9:4. PMC: 2818695. DOI: 10.1186/1476-4598-9-4. View